In the latest close session, Merck (MRK) was down 1.18% at $114.50. This move was narrower than the S&P 500's daily loss of 1.36%. Elsewhere, the Dow saw a downswing of 1.64%, while the tech-heavy ...

MRK, is presenting new long term data on its GARDASIL 9 and GARDASIL HPV vaccines at a major international HPV congress. The data highlight vaccine effectiveness against cancers and diseases caused by ...

Is MRK a good stock to buy now? We came across a bullish thesis on Merck & Co., Inc. on Investomine’s Substack. In this ...

Shares of Merck & Co. Inc. MRK slipped 1.18% to $114.50 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.36% to 6,624.70 ...

If you are wondering whether Merck's current share price still offers value, this article will walk through what the numbers are really saying about the stock. Merck closed at US$115.61, with returns ...

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Value Fund” ...

A giant in the healthcare space, Merck (NYSE:MRK) shares are up 13.5% year-to-date and trading near $119.47, yet retail sentiment on Reddit has slipped from a bullish 63 over the past quarter to a ...

Merck MRK is set to report its fourth-quarter and full-year 2025 earnings on Feb. 3, before market open. The Zacks Consensus Estimate for fourth-quarter sales and earnings is pegged at $16.19 billion ...

Disclosed in the latest SEC filing, a significant insider purchase on January 28, involves Johannes Oosthuizen, President at Merck & Co (NYSE:MRK). What Happened: A Form 4 filing with the U.S.